Literature DB >> 14617021

Angiotensin I-converting enzyme is expressed by erythropoietic cells of normal and myeloproliferative bone marrow.

Maruska Marusic-Vrsalovic1, Mara Dominis, Branimir Jaksic, Rajko Kusec.   

Abstract

It is proposed that a locally active, intrinsic renin-angiotensin system (RAS) exists in the bone marrow (BM) and plays a role in regulating haematopoiesis. Angiotensin II type I receptor has been detected on erythroid burst-forming unit-derived cells; its antagonist losartan and angiotensin I-converting enzyme (ACE) inhibitors can suppress erythropoiesis. The possible role of ACE/RAS in BM was investigated by evaluating ACE expression in normal BM, several myeloproliferative disorders and myelodysplasia. Immunohistochemical studies showed that erythroid elements expressed ACE protein in both normal and disturbed haematopoiesis. The presence of ACE in erythroid cells suggests another mechanism for direct ACE inhibitor activity in erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617021     DOI: 10.1046/j.1365-2141.2003.04598.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure.

Authors:  Eran Leshem-Rubinow; Arie Steinvil; David Zeltser; Shlomo Berliner; Ori Rogowski; Raanan Raz; Gabriel Chodick; Varda Shalev
Journal:  Mayo Clin Proc       Date:  2012-11-07       Impact factor: 7.616

2.  Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia.

Authors:  Yavuz Beyazit; Salih Aksu; Ibrahim C Haznedaroglu; Murat Kekilli; Muge Misirlioglu; Serdar Tuncer; Jale Karakaya; Ebru Koca; Yahya Buyukasik; Nilgun Sayinalp; Hakan Goker
Journal:  J Natl Med Assoc       Date:  2007-01       Impact factor: 1.798

3.  Pharmacologic ACE-Inhibition Mitigates Radiation-Induced Pneumonitis by Suppressing ACE-Expressing Lung Myeloid Cells.

Authors:  Guru Prasad Sharma; Brian L Fish; Anne C Frei; Jayashree Narayanan; Tracy Gasperetti; Dana Scholler; Lauren Pierce; Nathan Szalewski; Noah Blue; Meetha Medhora; Heather A Himburg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2022-01-29       Impact factor: 8.013

4.  Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease.

Authors:  Ebru Koca; Ibrahim C Haznedaroglu; Aysegul Uner; Nilgün Sayinalp; Arzu E Saglam; Hakan Goker; Osman I Ozcebe
Journal:  J Natl Med Assoc       Date:  2007-11       Impact factor: 1.798

5.  Discontinuation of the renin-angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes.

Authors:  George Pavlidis; Sotirios G Papageorgiou; Efthimia Bazani; Anthi Bouchla; Eirini Glezou; Konstantinos Gkontopoulos; Thomas Thomopoulos; Vasiliki Pappa; Demetrios V Vlahakos
Journal:  Ther Adv Hematol       Date:  2021-01-13

6.  Local Renin-Angiotensin system in normal hematopoietic and multiple myeloma-related progenitor cells.

Authors:  Burak Uz; Suzin Çatal Tatonyan; Müge Sayitoğlu; Yücel Erbilgin; Ozden Hatırnaz; Salih Aksu; Yahya Büyükaşık; Nilgün Sayınalp; Hakan Göker; Osman İ Ozcebe; Uğur Ozbek; Ibrahim C Haznedaroğlu
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.